Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Eledon Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +2 vs. Q2 2024
- Shares held
- 18.5M
- +381.1K (+2.1%) vs. Q2 2024
- Total value
- $46.0M
- −$1.77M (−3.7%) vs. Q2 2024
- New holders
- 3
- 9 more added
- Sold out
- 1
- 6 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 4 | $10 | 0.00% | −54,997−100.0% | Reduced |
| FMR LLC | 17 | $42 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 97 | $242 | 0.00% | +6+6.6% | Added |
| Tower Research Capital LLC (TRC) | 1,532 | $3.81K | 0.00% | −15,426−91.0% | Reduced |
| Bank of America Corp | 6,816 | $17.0K | 0.00% | −20.0% | Reduced |
| Two Sigma Securities, LLC | 11,027 | $27.5K | 0.00% | +11,027 | New |
| Clarity Capital Partners LLC | 11,500 | $28.6K | 0.02% | +11,500 | New |
| Pathstone Holdings, LLC | 13,029 | $32.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 14,987 | $37.3K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 16,726 | $40.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 19,870 | $49.5K | 0.00% | −1,918−8.8% | Reduced |
| Marco Investment Management LLC | 30,344 | $75.6K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 33,400 | $83.2K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 34,223 | $85.2K | 0.00% | +3,990+13.2% | Added |
| Ingalls & Snyder LLC | 51,849 | $129.0K | 0.01% | 00.0% | Unchanged |
| Jmac Enterprises LLC | 58,041 | $144.5K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 83,471 | $207.8K | 0.00% | +81,316+3,773.4% | Added |
| Northern Trust Corp | 91,893 | $228.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 135,873 | $338.3K | 0.00% | −900−0.7% | Reduced |
| State Street Corp | 161,492 | $402.1K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 215,868 | $537.5K | 0.00% | +215,868 | New |
| CM Management, LLC | 275,000 | $684.8K | 0.55% | +115,000+71.9% | Added |
| Geode Capital Management, LLC | 378,058 | $941.5K | 0.00% | +33,569+9.7% | Added |
| Ensign Peak Advisors, Inc | 443,001 | $1.10M | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 500,000 | $1.25M | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 600,000 | $1.49M | 0.13% | 00.0% | Unchanged |
| Woodline Partners LP | 842,892 | $2.10M | 0.02% | +167,649+24.8% | Added |
| Sphera Funds Management Ltd. | 1,297,321 | $3.23M | 0.53% | +3000.0% | Added |
| Zimmer Partners, LP | 1,434,727 | $3.57M | 0.07% | −674,977−32.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 1,500,000 | $3.73M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,565,487 | $3.90M | 0.00% | +461,092+41.8% | Added |
| Armistice Capital, LLC | 2,364,000 | $5.89M | 0.15% | +28,000+1.2% | Added |
| BVF Inc | 6,293,282 | $15.7M | 0.46% | 00.0% | Unchanged |
| Royal Bank of Canada | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |